Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synergy CHCSNYR +34.66% Gross Margin % is 72.29% as of Mar. 2026, which is 7% above its 10-year median of 67.87. The stock has 3 warning signs investors should review. Among 120 Medical Distribution companies, Synergy CHC ranks better than 96.67% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Synergy CHC had a gross margin of 72.29% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Synergy CHC Gross Margin % Related Terms
Synergy CHC Gross Margin % Historical Data
* Premium members only.
The historical data trend for Synergy CHC's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Synergy CHC's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synergy CHC Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Synergy CHC's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Synergy CHC's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Synergy CHC (SNYR) has a Gross Margin % of 72.29% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Synergy CHC and its competitors. This is near median its historical median of 67.87. Over the past decade, Synergy CHC's Gross Margin % has ranged from 44.44 to 74.99. According to the industry distribution chart, Synergy CHC ranks #4 out of 120 companies in the Medical Distribution industry, placing it in the top 3.3%.
Is Synergy CHC's Gross Margin % too high?
Synergy CHC's current Gross Margin % of 72.29% is near median its 10-year median of 67.87. Over the past 10 years, this metric has ranged from a low of 44.44 to a high of 74.99. The Medical Distribution industry median Gross Margin % is 15.03. Synergy CHC's value of 72.29% is 381% above this industry median. Based on the distribution chart, Synergy CHC ranks #4 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers.
How does Synergy CHC's Gross Margin % compare to MEDS and MCK?
According to the Medical Distribution industry distribution chart, Synergy CHC ranks #4 out of 120 companies for Gross Margin %. This places Synergy CHC in the top 3% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 15.03. Synergy CHC's value of 72.29% is 381% above this benchmark. Historically, Synergy CHC's own Gross Margin % has ranged from 44.44 to 74.99 over the past decade. While the company's 10-year median is 67.87 vs. the industry median of 15.03, Synergy CHC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 15.03, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synergy CHC's current Gross Margin % of 72.29% is 381% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Synergy CHC and its competitors. For the Medical Distribution industry, the median Gross Margin % is 15.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synergy CHC's current Gross Margin % is 72.29%, which is near median its own 10-year median of 67.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synergy CHC stock overvalued right now?
Based on GuruFocus' analysis, Synergy CHC (SNYR) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.11 — trading 90% below its estimated fair value. The current Gross Margin % is 72.29%, which is near median its 10-year median of 67.87 and 381% above the Medical Distribution industry median of 15.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Synergy CHC (SNYR), the current Gross Margin % is 72.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer-branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen, amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNYR has been successfully added to your 
